Management of cardiovascular disease using an mHealth tool: a randomized clinical trial
Abstract Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and morbidity worldwide. This randomized controlled, single-center, open-label trial tested the impact of a mobile health (mHealth) service tool optimized for ASCVD patient care. Patients with clinical ASCVD were enr...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/173b60bfeae74628b592820139354d21 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:173b60bfeae74628b592820139354d21 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:173b60bfeae74628b592820139354d212021-12-05T12:06:13ZManagement of cardiovascular disease using an mHealth tool: a randomized clinical trial10.1038/s41746-021-00535-z2398-6352https://doaj.org/article/173b60bfeae74628b592820139354d212021-12-01T00:00:00Zhttps://doi.org/10.1038/s41746-021-00535-zhttps://doaj.org/toc/2398-6352Abstract Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and morbidity worldwide. This randomized controlled, single-center, open-label trial tested the impact of a mobile health (mHealth) service tool optimized for ASCVD patient care. Patients with clinical ASCVD were enrolled and randomly assigned to the intervention or control group. Participants in the intervention group were provided with a smartphone application named HEART4U, while a dedicated interface integrated into the electronic healthcare record system was provided to the treating physicians. A total of 666 patients with ASCVD were enrolled, with 333 patients in each group. The estimated baseline 10-year risk of cardiovascular disease was 9.5% and 10.8% in the intervention and control groups, respectively, as assessed by the pooled cohort risk equations. The primary study endpoint was the change in the estimated risk at six months. The estimated risk increased by 1.3% and 1.1%, respectively, which did not differ significantly (P = 0.821). None of the secondary study endpoints showed significant differences between the groups. A post-hoc subgroup analysis showed the benefit was greater if a participant in the intervention group accessed the application more frequently. The present study demonstrated no significant benefits associated with the use of the mHealth tool in terms of the predefined study endpoints in stable patients with ASCVD. However, it also suggested that motivating patients to use the mHealth tool more frequently may lead to greater clinical benefit. Better design with a positive user experience needs to be considered for developing future mHealth tools for ASCVD patient care. Trial Registration: ClinicalTrials.gov NCT03392259Si-Hyuck KangHyunyoung BaekJihoon ChoSeok KimHee HwangWonjae LeeJin Joo ParkYeonyee E. YoonChang-Hwan YoonYoung-Seok ChoTae-Jin YounGoo-Yeong ChoIn-Ho ChaeDong-Ju ChoiSooyoung YooJung-Won SuhNature PortfolioarticleComputer applications to medicine. Medical informaticsR858-859.7ENnpj Digital Medicine, Vol 4, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Computer applications to medicine. Medical informatics R858-859.7 |
spellingShingle |
Computer applications to medicine. Medical informatics R858-859.7 Si-Hyuck Kang Hyunyoung Baek Jihoon Cho Seok Kim Hee Hwang Wonjae Lee Jin Joo Park Yeonyee E. Yoon Chang-Hwan Yoon Young-Seok Cho Tae-Jin Youn Goo-Yeong Cho In-Ho Chae Dong-Ju Choi Sooyoung Yoo Jung-Won Suh Management of cardiovascular disease using an mHealth tool: a randomized clinical trial |
description |
Abstract Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and morbidity worldwide. This randomized controlled, single-center, open-label trial tested the impact of a mobile health (mHealth) service tool optimized for ASCVD patient care. Patients with clinical ASCVD were enrolled and randomly assigned to the intervention or control group. Participants in the intervention group were provided with a smartphone application named HEART4U, while a dedicated interface integrated into the electronic healthcare record system was provided to the treating physicians. A total of 666 patients with ASCVD were enrolled, with 333 patients in each group. The estimated baseline 10-year risk of cardiovascular disease was 9.5% and 10.8% in the intervention and control groups, respectively, as assessed by the pooled cohort risk equations. The primary study endpoint was the change in the estimated risk at six months. The estimated risk increased by 1.3% and 1.1%, respectively, which did not differ significantly (P = 0.821). None of the secondary study endpoints showed significant differences between the groups. A post-hoc subgroup analysis showed the benefit was greater if a participant in the intervention group accessed the application more frequently. The present study demonstrated no significant benefits associated with the use of the mHealth tool in terms of the predefined study endpoints in stable patients with ASCVD. However, it also suggested that motivating patients to use the mHealth tool more frequently may lead to greater clinical benefit. Better design with a positive user experience needs to be considered for developing future mHealth tools for ASCVD patient care. Trial Registration: ClinicalTrials.gov NCT03392259 |
format |
article |
author |
Si-Hyuck Kang Hyunyoung Baek Jihoon Cho Seok Kim Hee Hwang Wonjae Lee Jin Joo Park Yeonyee E. Yoon Chang-Hwan Yoon Young-Seok Cho Tae-Jin Youn Goo-Yeong Cho In-Ho Chae Dong-Ju Choi Sooyoung Yoo Jung-Won Suh |
author_facet |
Si-Hyuck Kang Hyunyoung Baek Jihoon Cho Seok Kim Hee Hwang Wonjae Lee Jin Joo Park Yeonyee E. Yoon Chang-Hwan Yoon Young-Seok Cho Tae-Jin Youn Goo-Yeong Cho In-Ho Chae Dong-Ju Choi Sooyoung Yoo Jung-Won Suh |
author_sort |
Si-Hyuck Kang |
title |
Management of cardiovascular disease using an mHealth tool: a randomized clinical trial |
title_short |
Management of cardiovascular disease using an mHealth tool: a randomized clinical trial |
title_full |
Management of cardiovascular disease using an mHealth tool: a randomized clinical trial |
title_fullStr |
Management of cardiovascular disease using an mHealth tool: a randomized clinical trial |
title_full_unstemmed |
Management of cardiovascular disease using an mHealth tool: a randomized clinical trial |
title_sort |
management of cardiovascular disease using an mhealth tool: a randomized clinical trial |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/173b60bfeae74628b592820139354d21 |
work_keys_str_mv |
AT sihyuckkang managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT hyunyoungbaek managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT jihooncho managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT seokkim managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT heehwang managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT wonjaelee managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT jinjoopark managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT yeonyeeeyoon managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT changhwanyoon managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT youngseokcho managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT taejinyoun managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT gooyeongcho managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT inhochae managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT dongjuchoi managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT sooyoungyoo managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial AT jungwonsuh managementofcardiovasculardiseaseusinganmhealthtoolarandomizedclinicaltrial |
_version_ |
1718372238820900864 |